ELECTRONIC SYSTEMS TECHNOLOGY INC (ELST)·Q3 2014 Earnings Summary
Executive Summary
- Q3 2014 deteriorated materially: revenue fell to $380,407 and ELST posted a net loss of $(93,806), or $(0.02) per share, versus $574,507 revenue and $0.01 EPS in Q3 2013; gross margin compressed and operating loss widened, driven by lower volumes and mix .
- Sequentially, revenue declined from $532,262 in Q2 2014 to $380,407 and profitability reversed from $12,912 net income to a $(93,806) net loss, reflecting deleveraging of fixed costs and a less favorable mix .
- Management attributed the downturn to decreased core product sales and continuing economic concerns in foreign markets; export sales dropped to 3% of revenue (vs. 17% a year ago), and two domestic customers accounted for 15.5% and 11.5% of quarterly sales, highlighting concentration risk .
- Balance sheet remains debt-free with cash rising to $952,484 and current ratio improving to 61.4x; no dividend declared; no formal guidance issued .
What Went Well and What Went Wrong
What Went Well
- Strengthened liquidity and no long-term debt: cash and equivalents increased to $952,484; current assets of $2,896,149 vs. current liabilities of $47,168 (61.4x current ratio); long-term debt: -0- .
- Operating discipline on marketing: marketing expense decreased slightly YoY ($111,456 vs. $114,188) as management curtailed travel, though total OpEx rose on R&D and G&A .
- Management investing for product roadmap: inventories increased partly to support new ESTeem 210 and 195 products; R&D up due to subcontracted engineering and payroll to support development .
Quote: “Management believes the decrease in quarterly and year to date sales revenues is due to decreased core products and continuing economic concerns in foreign markets.”
What Went Wrong
- Topline weakness and deleverage: revenue declined 33.8% YoY and 28.5% QoQ; operating swung to a $(98,956) loss (vs. $59,254 profit in Q3 2013 and $10,835 profit in Q2 2014) as fixed costs were not leveraged .
- Margin pressure: cost of sales percentage increased versus prior periods; management cited product mix and unleveraged manufacturing overhead; gross profit fell to $190,280 from $319,333 a year ago .
- Export weakness and concentration risk: export sales were just 3% of net revenue vs. 17% last year; two domestic customers comprised 15.5% and 11.5% of sales; backlog remained small at ~$12,274 .
Financial Results
Note: Minor rounding differences exist between the 8-K press release and 10-Q (e.g., sales $380,408 vs. $380,407; net loss $(93,804) vs. $(93,806)). Calculations below use 10-Q amounts .
Change vs. prior periods (Q3 2014 reference):
- Vs Q3 2013: Revenue −33.8%; Gross Profit −40.4%; Operating Income −$158,210; EPS −$0.03 (calc; sources above) .
- Vs Q2 2014: Revenue −28.5%; Gross Profit −37.1%; Operating Income −$109,791; EPS −$0.02 (calc; sources above) .
Segment revenue mix (Domestic/Foreign):
KPIs and balance sheet/liquidity:
Guidance Changes
No formal financial guidance was provided. No dividends declared in 2014.
Earnings Call Themes & Trends
No Q3 2014 earnings call transcript was available; themes below reflect MD&A and press release commentary.
Management Commentary
- “Management believes the decrease in quarterly and year to date sales revenues is due to decreased core products and continuing economic concerns in foreign markets.”
- “During the quarter ended September 30, 2014, the Company had $12,750 in foreign export sales… compared with $94,863 for the same quarter of 2013.”
- “Cost of sales percentage for the third quarter of 2014 and 2013 was 47% and 41%, respectively. The cost of sales increase… is the result of the product mix… and manufacturing overhead that was not leveraged.”
- “Research and Development expenses increased $16,684… due to increased subcontracted engineering expertise and payroll.”
- “The Corporation had a sales order backlog of approximately $12,274 as of September 30, 2014… customers generally place orders on an ‘as needed basis.’”
Q&A Highlights
No earnings call/Q&A was available for Q3 2014; no management Q&A clarifications disclosed in filings or press release .
Estimates Context
- Wall Street consensus estimates from S&P Global for ELST were unavailable for Q3 2014 (no mapping/coverage). As a result, we cannot provide vs-consensus comparisons for revenue or EPS this quarter.
- Given the lack of coverage and microcap status, estimates are unlikely to anchor near-term trading; investors should focus on order trends, mix, and domestic end-market recovery (see Financial Results and Themes) .
Key Takeaways for Investors
- Volume and mix drove a sharp earnings reversal: revenue down 28.5% QoQ and 33.8% YoY with gross margin contraction to ~50%, yielding a $(0.02) loss; sustained recovery requires rebuilding volume and mix quality .
- Export markets were a notable drag (3% of sales vs. 17% LY) amid macro softness; focus shifts to domestic pipeline and timing of project-based orders .
- Fixed-cost deleverage was evident: operating loss of $(98,956) on $289,237 OpEx; near-term profitability hinges on volume/mix and OpEx control .
- Liquidity is solid and debt-free, providing flexibility through a downturn; cash rose to $952,484 and current ratio to 61.4x, though backlog is modest ($12,274) .
- Watch product transition and R&D spend tied to ESTeem 210/195; success could improve mix and margins, but costs must be monitored .
- Internal control material weakness remains (segregation of duties); not cash-impacting but a governance overhang to monitor .
- Without Street estimates, catalysts will be order wins, customer concentration risk (two customers = 27% of Q3 sales), and any stabilization in export demand .